Severe cardiovascular features of Marfan syndrome in childhood: Just another manifestation or a specific entity?

International Journal of Cardiovascular Imaging

Volumn 20, Issue 4, 2004, Pages 269-270

  Groenink, Maarten ^a   Mulder, Barbara J M ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FIBRILLIN 1;

AORTA ANEURYSM; AORTA VALVE REGURGITATION; AUTOSOMAL DOMINANT INHERITANCE; CARDIOVASCULAR DISEASE; CHILDHOOD DISEASE; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; EDITORIAL; GENE MUTATION; HEART DILATATION; HEART LEFT VENTRICLE; HEART SURGERY; HEMODYNAMICS; HUMAN; MARFAN SYNDROME; ARTERY DILATATION; ASCENDING AORTA; CASE REPORT; CONGESTIVE HEART FAILURE; EXON; GENETIC ASSOCIATION; HEART LEFT VENTRICLE HYPERTROPHY; MITRAL VALVE REGURGITATION; PHENOTYPE; SCHOOL CHILD; TRICUSPID VALVE REGURGITATION;

EID: 4544336032     PISSN: 15695794     EISSN: 18758312     Source Type: Journal    
DOI: 10.1023/B:CAIM.0000041980.75452.9f     Document Type: Editorial

References (5)

1. Pyeritz RE. The Marfan syndrome. Annu Rev Med 2000; 51: 481-510.
2. Dietz HC, Cutting GR, Pyeritz RE, et al. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature 1991; 352(6333): 337-339.
3. Shores J, Berger KR, Murphy EA, Pyeritz RE. Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan's syndrome. N Engl J Med 1994; 330(19): 1335-1341.
4. Groenink M, de Roos A, Mulder BJM, et al. Changes in aortic distensibility and pulse wave velocity assessed with magnetic resonance imaging following beta-blocker therapy in the Marfan syndrome. Am J Cardiol 1998; 82: 203-208.
5. Yin FC, Brin KP, Ting CT, Pyeritz RE. Arterial hemodynamic indexes in Marfan's syndrome. Circulation 1989 79(4): 854-862.